Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Brian J. Carney"'
Autor:
Brian J. Carney, Erik J. Uhlmann, Maneka Puligandla, Charlene Mantia, Griffin M. Weber, Donna S. Neuberg, Jeffrey I. Zwicker
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 5, Pp 860-865 (2020)
Abstract Background Intracranial hemorrhage (ICH) is a common and often devastating outcome in patients with brain tumors. Despite this, there is little evidence to guide anticoagulation management following an initial ICH event. Objectives To analyz
Externí odkaz:
https://doaj.org/article/6f1ca3ab66cb4ba886a18fde187515ce
Publikováno v:
Thrombosis Research. 227:8-16
Autor:
Vinay Shah, Donna Neuberg, Abigail Bartosic, Manila Gaddh, Gemlyn George, Jeffrey I. Zwicker, Siyang Ren, Thomas Bogue, Tzu-Fei Wang, Amer Al Homssi, Gregory C. Connolly, Brian J. Carney, Lisa Baumann Kreuziger
Publikováno v:
Blood Advances
Key Points In patients with cancer with VTE and thrombocytopenia, modified-dose anticoagulation was associated with a lower rate of major hemorrhage.In this cohort, recurrent VTE was not observed after initiation of modified-dose anticoagulation.
Autor:
Eva N. Hamulyák, Jeffrey I. Zwicker, Maya Avrahami, Jelijn J. Knip, Pia Raanani, Avi Leader, Brian J. Carney, Shlomit Yust-Katz, Saskia Middeldorp, Harry R. Büller, Michiel Coppens, Galia Spectre, Ludo F. M. Beenen, Shira Rozenblatt, Oded Icht
Publikováno v:
Blood advances, 4(24), 6291-6297. The American Society of Hematology
Blood Adv
Blood advances, 4(24), 6291-6297. American Society of Hematology
Blood Adv
Blood advances, 4(24), 6291-6297. American Society of Hematology
Direct oral anticoagulants (DOACs) are increasingly prescribed in treatment of cancer-associated thrombosis, but limited data exist regarding safety of DOACs in patients with brain metastases. We aimed to determine the incidence of intracranial hemor
Autor:
Donna Neuberg, Erik J. Uhlmann, Jeffrey I. Zwicker, Griffin M. Weber, Brian J. Carney, Charlene Mantia, Maneka Puligandla
Publikováno v:
Journal of Thrombosis and Haemostasis. 17:72-76
Essentials Intracranial hemorrhage (ICH) is common in patients with brain tumors. We compared rates of ICH with DOACs and low molecular weight heparin. DOACs were associated with a lower incidence of ICH in primary brain tumors. DOACs appear safe to
Publikováno v:
Transplantation and cellular therapy. 27(3)
Autor:
Charlene Mantia, Erik J. Uhlmann, Brian J. Carney, Donna Neuberg, Jeffrey I. Zwicker, Maneka Puligandla, Griffin M. Weber
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 5, Pp 860-865 (2020)
Research and Practice in Thrombosis and Haemostasis, Vol 4, Iss 5, Pp 860-865 (2020)
Background Intracranial hemorrhage (ICH) is a common and often devastating outcome in patients with brain tumors. Despite this, there is little evidence to guide anticoagulation management following an initial ICH event. Objectives To analyze the ris
Autor:
Laura E. Dodge, Joséphine A Cool, Brian J. Carney, Jason A. Freed, Rushad Patell, Natalia Forbath, Andrew J. Hale, Daniel N Ricotta, Brian K Persaud
Publikováno v:
Blood. 136:21-22
Background: Consistent classification of consult requests may lead to more productive, efficient, and collegial conversations about patient care, which can facilitate improved work satisfaction and an enhanced learning environment. We propose an orga
Autor:
Kyle Gowen, Siraj M. Ali, Paul A. VanderLaan, Deepa Rangachari, Brian J. Carney, Alexa B. Schrock, Daniel B. Costa
Publikováno v:
Lung Cancer. 114:108-110
Autor:
Brian J. Carney, Donna Neuberg, Griffin M. Weber, Charlene Mantia, Jeffrey I. Zwicker, Erik J. Uhlmann, Maneka Puligandla
Publikováno v:
Blood. 134:2438-2438
Introduction Both venous thromboembolism (VTE) and intracranial hemorrhage (ICH) are common potentially life-threatening complications of primary and metastatic brain tumors. Despite emerging evidence regarding the safety of anticoagulation in patien